Content referencing Rick Bright
Press Release
Senator Baldwin Questions FDA on Regulation and Oversight of Hydroxychloroquine
Concerns raised about the Trump Administration’s promotion of hydroxychloroquine
Jun 4th, 2020 by U.S. Sen. Tammy BaldwinConcerns raised about the Trump Administration’s promotion of hydroxychloroquine
Jun 4th, 2020 by U.S. Sen. Tammy Baldwin